Skip to main content
Premium Trial:

Request an Annual Quote

Strand and Pharmidex to Co-Promote, Co-Develop BBB Research Tools

NEW YORK, Feb. 21 (GenomeWeb News) - Strand Life Sciences and Pharmidex have entered into a co-marketing and -product development agreement, the companies said today.

 

Under the terms of the agreement, Strand and Pharmidex will promote each other's existing products and jointly develop new software to predict the ability of compounds to cross the blood-brain barrier, the companies said.

 

Strand will primarily provide in silico expertise, while Pharmidex will contribute its expertise in blood-brain barrier research, including in vitro, ex vivo, and in vivo methods.

 

Financial terms of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.